Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Allied Energy Corporation (AGYP)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0080+0.0000 (+0.63%)
At close: 01:42PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0080
Open0.0070
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0070 - 0.0086
52 Week Range0.0050 - 0.1360
Volume20,410
Avg. Volume147,995
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AGYP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ALLIED ENERGY CORPORATION NEVAD
    Analyst Report: Gilead Sciences, Inc.Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury (remdesivir) became the first approved treatment for COVID-19 in the U.S. Founded in 1987, the company is located in Foster City, California. It has operations in more than 35 countries and approximately 17,000 employees.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
Advertisement
Advertisement